Neil's research office is based at the Institute for Head and Neck Studies and Education (InHANSE), which is part of the Institute of Cancer and Genomic Sciences, at the University of Birmingham.
Neil's main research interest is thyroid cancer. He completed his PhD examining novel therapeutic targets for radio iodine-refractory thyroid cancer and has continued to have a strong translational research interest. His current focus is on clinical research into novel diagnostic and therapeutic strategies for thyroid cancer. He is a member of the trial steering group for the ELaTION multi-centre clinical trial, assessing the role of ultrasound elastography in diagnosing thyroid cancer. Neil is always seeking to develop new research collaborations with colleagues both in the UK and abroad.
Head and Neck Cancer
Neil is involved in both clinical and translational research in to head and neck squamous cell carcinoma, as well as salivary gland neoplasms and qualitative research examining patients' experiences of head and neck cancer and treatment.
Global Cancer Care
Neil is the co-lead for the International Collaboration On Improving Cancer Outcomes in low and middle income countries (ICOnIC). This group, initially working in Africa (ICOnIC Africa), comprises clinicians, allied healthcare professions, patient groups, NGOs, research and training bodies, and government policy makers in 16 African countries. The ICOnIC Africa group has begun examining the reasons for late presentation of head and neck cancer in Africa, alongside building research capacity and infrastructure on the continent.
Neil sits on the research committee of the African Organisation for Research and Training in Cancer (AORTIC), setting the agenda for cancer research in Africa, and helping to promote cancer research and supporting patients in Africa and beyond.